Development of TGF-β signalling inhibitors for cancer therapy

Jonathan M. Yingling(Eli Lilly (United States)), Kerry Blanchard(Eli Lilly (United States)), J. Scott Sawyer(Eli Lilly (United States))
Nature Reviews Drug Discovery
December 1, 2004
Cited by 546

Abstract


Related Papers

No related papers found

Powered by citation graph analysis